A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer (Q34192568)

31 July 2017

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer (English)

1 reference

31 July 2017

0 references

Ignacio Garrido-Laguna

4

object named as

Ignacio Garrido-Laguna

1 reference

31 July 2017

10

David Sidransky

1 reference

31 July 2017

Manuel Hidalgo

1

1 reference

31 July 2017

Elizabeth Bruckheimer

2

1 reference

31 July 2017

N V Rajeshkumar

3

1 reference

31 July 2017

Elizabeth De Oliveira

5

1 reference

31 July 2017

Belen Rubio-Viqueira

6

1 reference

31 July 2017

Steven Strawn

7

1 reference

31 July 2017

Michael J Wick

8

1 reference

31 July 2017

James Martell

9

1 reference

31 July 2017

14 June 2011

1 reference

Molecular Cancer Therapeutics

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

1311-1316

1 reference

31 July 2017

8

1 reference

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Gene expression profiling of the irinotecan pathway in colorectal cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4629061

An in vivo platform for translational drug development in pancreatic cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21673092

12 December 2020

inferred from PubMed ID database lookup

What can CCR do for you?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21673092

12 December 2020

inferred from PubMed ID database lookup

Cancer genomics: from discovery science to personalized medicine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21673092

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1158/1535-7163.MCT-11-0233

1 reference

release_5v34m4ufxvfn3pqqphgom7h56q

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5v34m4ufxvfn3pqqphgom7h56q

24 November 2022

mapped directly with Wikidata item

PMCID

4629061

1 reference

31 July 2017

1 reference